# Limits on WIMP dark matter with NaI(Tl) crystals in three years of COSINE-100 data

Preprint · G. H. Yu, N. Carlin, J. Y. Cho, J. J. Choi, S. Choi, A. C. Ezeribe, L. E. Franca, C. Ha, I. S. Hahn, S. J. Hollick, E. J. Jeon, H. W. Joo, W. G. Kang, M. Kauer, B. H. Kim, H. J. Kim, J. Kim, K. W. Kim, S. H. Kim, S. K. Kim, W. K. Kim, Y. D. Kim, Y. H. Kim, Y. J. Ko, D. H. Lee and 34 more

- Archive id: arxiv:2501.13665
- Published: 2025-01-23
- arXiv: https://arxiv.org/abs/2501.13665
- Source URL: https://arxiv.org/abs/2501.13665
- PDF: https://arxiv.org/pdf/2501.13665
- Provenance: arxiv

## Abstract

We report limits on WIMP dark matter derived from three years of data collected by the COSINE-100 experiment with NaI(Tl) crystals, achieving an improved energy threshold of 0.7 keV. This lowered threshold enhances sensitivity in the sub-GeV mass range, extending the reach for direct detection of low-mass dark matter. Although no excess of WIMP-like events was observed, the increased sensitivity enabled a model-insensitive comparison between the expected WIMP signal rate-based on mass limits from our data-and DAMA's reported modulation amplitude. Our findings strongly disfavor the DAMA signal as originating from WIMP interactions, fully excluding DAMA/LIBRA 3$σ$ allowed regions and providing enhanced WIMP mass limits by an order of magnitude in the spin-independent model compared to previous results. In the spin-dependent model, cross-section upper limits were obtained in the mass range \[0.1-5.0\] GeV/c$^2$, with additional sensitivity to sub-GeV WIMPs through the inclusion of the Migdal effect. These results represent substantial progress in low-mass dark matter exploration and reinforce constraints on the longstanding DAMA claim.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.